Risk-based imaging after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial compares different imaging schedules after breast-conserving surgery for people with a higher risk of recurrence. It tests whether more frequent or different types of scans can catch any return of cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had breast cancer confirmed by biopsy.
- You had a lumpectomy (breast-conserving surgery) to remove the cancer.
- You finished your main treatment (like radiation or hormone therapy) as recommended.
- Your doctors consider you to have a higher-than-average risk of the cancer coming back.
- You are able to have regular follow-up scans.
- You are registered in a breast cancer registry in your country.
- You haven't had breast cancer in the same or opposite breast in the last 5 years (other than the one you're being treated for now).
- You have not had both breasts removed (double mastectomy).
- You do not have breast cancer that has spread to other parts of the body (metastatic).
- You are not pregnant at the time you join the study.
- You have no medical reason that would stop you from having scans (like an allergy to contrast dye or metal in your body if MRI is needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if changing the order of mammogram views makes the exam more comfortable for women who have had breast cancer surgery and radiation. You may be able to join if you are due for your first check-up mammogram after finishing treatment.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This trial tests a focused radiation treatment before surgery for early-stage breast cancer that is hormone receptor positive and HER2 negative. The goal is to give precise radiation only to the tumor, with the hope of reducing side effects and improving outcomes.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This study looks at how detailed breast imaging can help diagnose breast cancer when a mammogram is suspicious. If your mammogram result was “highly suspicious” and you have not had a biopsy yet, the trial may be able to use your images to improve future diagnosis.
This study tests a more thorough breast cancer screening program using MRI and other imaging for women at high risk. It aims to detect cancer earlier, which may improve treatment options and outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.